This $8.9 Million Targets a Stock Down 68% with Cash
A disciplined investor asks: can a modest, cash-backed bet on a distressed stock generate alpha? This article breaks ...
Yearly Tax Harvesting Strategy Index Funds
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articles
APM’s Michael Banner: HECM for Purchase Struggles Now
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
Rallies QuantumScape Just Crossed Milestone, Stocks Jump
QuantumScape reports its first 2025 customer billings and a major monetization milestone, triggering a roughly 5% sto...
Peloton's Pivot Signal? Is It a Buy for Investors Today
Peloton has swung from hype to hardship, but its AI-driven pivot could reshape its fortunes. This guide explains what...
Micron Stock Bubble Ready? A Practical Investor Guide
Memory chips power AI and data centers, but prices swing with cycles. This guide weighs whether micron stock bubble r...
Dave Ramsey Employee Paid Off $118K in Four Years Fast
A Ramsey Solutions employee paid off $118,000 in debt in four years by taking on two side jobs and strict budgeting. ...
Summit Funding Staff Amid CCM Deal Faces Mass Layoffs
Summit Funding plans large-scale layoffs as CrossCountry Mortgage advances its acquisition. About 163 employees will ...
Remitly Director's $522k Sale: Insider Moves and Insights
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
Alibaba Price Target Slashed as AI Push Drags Profits Lower
A major broker cuts Alibaba's target to $170 after a sharp drop in Q3 profits, driven by heavy AI investment. The clo...
Meta Platforms Aiming Trillion: What Investors Must Know
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Is Intuitive Surgical Right Now a Buy? Key Trends for ISRG
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status